Desmopressin does not reduce bleeding and transfusion requirements in congenital heart operations

Annals of Thoracic Surgery

Volumn 70, Issue 6, 2000, Pages 1923-1930

  Oliver Jr , William C ^a   Santrach, Paula J ^b   Danielson, Gordon K ^b   Nuttall, Gregory A ^b   Schroeder, Darrell R ^b   Ereth, Mark H ^b  

^a MAYO CLINIC   (United States)

^b Mayo Clinic ^*

Author keywords

[No Author keywords available]

Indexed keywords

DESMOPRESSIN; PLACEBO; PROTAMINE;

ADOLESCENT; ADULT; ANESTHESIOLOGICAL TECHNIQUES; ARTICLE; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CHILD; CLINICAL TRIAL; CONGENITAL HEART DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEART SURGERY; HUMAN; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE HEMORRHAGE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BLOOD COAGULATION TESTS; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CHILD; CHILD, PRESCHOOL; DEAMINO ARGININE VASOPRESSIN; DOUBLE-BLIND METHOD; FEMALE; HEART DEFECTS, CONGENITAL; HEMOSTASIS, SURGICAL; HUMANS; INFANT; MALE; PROSPECTIVE STUDIES; REOPERATION;

EID: 0034528784     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(00)02176-7     Document Type: Article

References (34)

1. Predisposing factors and management of hemorrhage following open heart surgery
2. Comparison of the hemostatic effects of fresh whole blood, stored whole blood and components after open heart surgery in children
3. Predicting and treating coagulopathies after cardiopulmonary bypass in children
4. Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations
5. HIV transmission through blood, tissues, and organs
6. Perioperative approaches to coagulation defects
7. Hematologic changes during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgical blood loss
8. Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: A multivariate analysis in cardiac surgical patients
9. Bleeding patterns after open-heart surgery
10. Desmopressin. A nontransfusional form of treatment for congenital and acquired bleeding disorders
11. Shortening of the bleeding time by 1-deamino-8-D-arginine vasopressin in various bleeding disorders
12. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery: A double-blind randomized trial
13. A trial of desmopressin (1-desamino-8-D-arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery
14. The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification
15. Treatment of severe platelet dysfunction and hemorrhage after cardiopulmonary bypass: Reduction in blood product usage with desmopressin
16. The effect of desmopressin on reducing blood loss in cardiac surgery - A meta-analysis of double-blind, placebo-controlled trials
17. Hyponatremia and seizures in young children given DDAVP
18. Desmopressin acetate is a mild vasodilator that does not reduce blood loss in uncomplicated cardiac surgical procedures
19. The effect of desmopressin acetate (DDAVP) on postoperative blood loss after cardiac operations in children
20. Desmopressin does not decrease bleeding after cardiac operation in young children
21. Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin
22. The effects of preoperative aspirin therapy on platelet function in cardiac surgery
23. Comparison of viscoelastic measures of coagulation after cardiopulmonary bypass
24. Use of desmopressin (DDAVP) in controlling aspirin-induced coagulopathy after cardiac surgery
25. Effects of desmopressin acetate on platelet aggregation, von Willebrand factor, and blood loss after cardiac surgery with extracorporeal circulation
26. The role of von Willebrand factor in haemostasis and blood loss during and after cardiopulmonary bypass surgery
27. DDAVP shortens the prolonged bleeding times of patients with severe von Willebrand disease treated with cryoprecipitate. Evidence for a mechanism of action independent of released von Willebrand factor
28. DDAVP-induced enhancement of platelet retention: Its dependence on platelet-von Willebrand factor and the platelet receptor GP IIb/IIIa
29. Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery
30. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: A prospective, blinded, randomized study
31. Guidelines for transfusion support in patients undergoing coronary artery bypass grafting
32. Changes in blood coagulation during and following cardiopulmonary bypass: Lack of correlation with clinical bleeding
33. Blood conservation in cardiac surgery
34. Conservation of blood during cardiovascular surgery